P2B-111

Stanford University (Stanford, CA) › P2B-111

P2B-111

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Stanford University (Stanford, CA) · Dr. Nolan
consented 2013-05-10

completed

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 2 asthenia with onset in cycle 6 (2013-09-22); assessed as not related to study drug (unlikely); resolved 2013-10-07.

moderate assessed

Grade 1 constipation with onset in cycle 6 (2013-09-10); assessed as not related to study drug (unlikely); resolved 2013-09-13.

mild assessed

Grade 1 dyspnoea with onset in cycle 4 (2013-07-26); assessed as not related to study drug (not related); resolved 2013-08-23.

mild assessed

Grade 2 alopecia with onset in cycle 1 (2013-06-09); assessed as related to study drug (probable); not resolved at last follow-up.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.